secwatch.observer — SEC 8-K summary
======================================

Issuer:     Praxis Precision Medicines, Inc. (PRAX)
CIK:        0001689548
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001689548-23-000113
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Praxis terminates $125M ATM equity facility with Jefferies; had raised $42.7M
-----------------------------------------------------------------------------

- Terminated Open Market Sale Agreement with Jefferies on June 15, 2023; effective after 10 trading days.
- Facility allowed sales of up to $125M; company had sold 18,279,207 shares for $42.7M gross proceeds.
- No termination penalties; termination is at the company's discretion per Section 7(b).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689548/000168954823000113/0001689548-23-000113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689548/000168954823000113/prax-20230615.htm
  HTML page:      https://secwatch.observer/filing/0001689548-23-000113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer